GreenRGuXKline-RogersEFroehlichJMacePGrayB, et al. Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry. Pediatr Nephrol. 2016;31(4):641-650.
2.
GornikHLPersuAAdlamDAparicioLSAziziMBoulangerM, et al. First international consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24(2):164-189.
3.
KimESHOlinJWFroehlichJBGuXBacharachJMGrayBH, et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol. 2013;62(21):2026-2028.
4.
LouisRLevy-ErezDCahillAMMeyersKE. Imaging studies in pediatric fibromuscular dysplasia: a single center experience. Pediatr Nephrol. 2018;33(9):1593-1599.
5.
OlinJWGornikHLBacharachJMBillerJFineLJGrayBH, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions—a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048-1078.
6.
BrinzaEGrabinskiVDurgaSO’ConnorSYesenkoSLKimESH, et al. Lower extremity fibromuscular dysplasia: clinical manifestations, diagnostic testing, and approach to management. Angiology. 2017;68(8):722-727.
7.
NguyenNSharmaAWestJKSerhalMBrinzaEGornikHL, et al. Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia. J Vasc Surg. 2017;66(2):554-563.
8.
EdwardsJMAntoniusJIPorterJM. Critical hand ischemia caused by forearm fibromuscular dysplasia. J Vasc Surg. 1985;2(3):459-463.
9.
StinnettDMGrahamJMEdwardsWD. Fibromuscular dysplasia and thrombosed aneurysm of the popliteal artery in a child. J Vasc Surg. 1987;5(5):769-772.
10.
KayssiAShaikhFRoche-NagleGBrandaoLRWilliamsSARubinBB. Management of acute limb ischemia in the pediatric population. J Vasc Surg. 2014;60:106-110.
11.
ThomazMJLuconAMPraxedesJNBortolottoLASrougiM. The role of nephrectomy of the atrophic kidney in bearers of renovascular hypertension. Int Braz J Urol. 2010;36(2):159-170.
